Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Molecular Endocrinology (Baltimore, Md.)|September 15, 2015
Minireview: Were the IGF Signaling Inhibitors All Bad?Heather Beckwith, Douglas YeeEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 10, 2014
Insulin-like growth factors, insulin, and growth hormone signaling in breast cancer: implications for targeted therapyHeather Beckwith, Douglas YeeThe Breast Journal|February 23, 2021
Synchronous breast carcinoma and peritoneal mesotheliomaSaranya Prathibha, Heather Beckwith, Robert A Kratzke, et al.Breast Cancer (Tokyo, Japan)|January 2, 2021
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysisHaiyun Wang, Shijia Zhang, Douglas Yee, et al.JNCI Cancer Spectrum|January 6, 2021
Sources of Medical Information for Oncology Physicians During the COVID-19 Pandemic: Results From a National Cross-Sectional SurveyHelen M Parsons, Rachel I Vogel, Anne H Blaes, et al.Breast Cancer Research and Treatment|October 30, 2021
The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancerJ Asher Jenkins, Schelomo Marmor, Jane Yuet Ching Hui, et al.Archives of Pathology & Laboratory Medicine|March 13, 2018
Distribution of 21-Gene Recurrence Scores Among Breast Cancer Histologic SubtypesScott Kizy, Jing Li Huang, Schelomo Marmor, et al.Springerplus|February 4, 2015
Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatmentAnne Blaes, Daniel Duprez, Todd Defor, et al.Breast Cancer Research and Treatment|August 13, 2017
Vascular function in breast cancer survivors on aromatase inhibitors: a pilot studyAnne Blaes, Heather Beckwith, Natalia Florea, et al.Breast Cancer Research and Treatment|September 10, 2018
Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinomaJing Li Huang, Scott Kizy, Schelomo Marmor, et al.Pageof 3